Onxeo S.A. announced that Prof. Jean-Pierre Kinet, M.D., of Harvard Medical School, and Jean-Pierre Bizzari, M.D., have been appointed Observers to the Board of Directors, effective immediately. Their appointments as full board members will be submitted to the shareholders during the next annual shareholders meeting. Dr. Bizzari most recent experience as Executive Vice-President of Clinical Oncology Development at Celgene.

Dr. Kinet current position as Professor of Pathology at Harvard Medical School (Boston - USA). Both will provide Onxeo with access to a very valuable network of academic, biotech, and pharma leaders in the United States and in Europe and will further enhance the current high level of expertise of the company's Board of Directors. In addition, Mr. Joseph Zakrzewski has been elected Chairman of Onxeo's Board of Directors, as announced in October 2015.

He is replacing Patrick Langlois, who has resigned. Mr. Zakrzewski has more than 25 years of experience in the global healthcare industry with a strong focus in the United States.